Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
zoltán csorba
Mar 13, 2023 11:21PM ET
go 10$
0
0
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
Please try another search
🙌 It's Here: the Only Stock Screener You'll Ever Need Get Started
24.980
+0.000
+0.00%
Type:
Equity
Market:
United States
- Volume: 0
- Bid/Ask: 0.000 / 0.000
- Day's Range: 24.980 - 25.000
Provention Bio
24.980
+0.000
+0.00%
- General
- Chart
- News & Analysis
- Financials
- Technical
- Forum
- Financial Summary
- Income Statement
- Balance Sheet
- Cash Flow
- Ratios
- Dividends
- Earnings
PRVB Income Statement
Featured here, the Income Statement (earnings report) for Provention Bio Inc, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).
| Period Ending: | 2022 31/12 |
2022 30/09 |
2022 30/06 |
2022 31/03 |
||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 10.81 | 0.756 | 0.746 | 0.58 | ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||
| Cost of Revenue, Total | 26.04 | 16.34 | 16.58 | 17.36 | ||||||||||||||||||||||||||||||
| Gross Profit | -15.23 | -15.58 | -15.83 | -16.78 | ||||||||||||||||||||||||||||||
| Total Operating Expenses | 50.98 | 29.83 | 30.58 | 29.66 | ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||
| Operating Income | -40.17 | -29.08 | -29.83 | -29.08 | ||||||||||||||||||||||||||||||
| Interest Income (Expense), Net Non-Operating | - | - | - | 0.06 | ||||||||||||||||||||||||||||||
| Gain (Loss) on Sale of Assets | - | - | - | - | ||||||||||||||||||||||||||||||
| Other, Net | -0.556 | -0.445 | -0.146 | -0.057 | ||||||||||||||||||||||||||||||
| Net Income Before Taxes | -39.61 | -28.63 | -29.69 | -29.02 | ||||||||||||||||||||||||||||||
| Provision for Income Taxes | -6.34 | - | - | -7.06 | ||||||||||||||||||||||||||||||
| Net Income After Taxes | -33.28 | -28.63 | -29.69 | -21.97 | ||||||||||||||||||||||||||||||
| Minority Interest | - | - | - | - | ||||||||||||||||||||||||||||||
| Equity In Affiliates | - | - | - | - | ||||||||||||||||||||||||||||||
| U.S GAAP Adjustment | - | - | - | - | ||||||||||||||||||||||||||||||
| Net Income Before Extraordinary Items | -33.28 | -28.63 | -29.69 | -21.97 | ||||||||||||||||||||||||||||||
| Total Extraordinary Items | - | - | - | - | ||||||||||||||||||||||||||||||
| Net Income | -33.28 | -28.63 | -29.69 | -21.97 | ||||||||||||||||||||||||||||||
| Total Adjustments to Net Income | - | - | - | - | ||||||||||||||||||||||||||||||
| Income Available to Common Excluding Extraordinary Items | -33.28 | -28.63 | -29.69 | -21.97 | ||||||||||||||||||||||||||||||
| Dilution Adjustment | - | - | - | - | ||||||||||||||||||||||||||||||
| Diluted Net Income | -33.28 | -28.63 | -29.69 | -21.97 | ||||||||||||||||||||||||||||||
| Diluted Weighted Average Shares | 87.44 | 83.12 | 64.72 | 63.4 | ||||||||||||||||||||||||||||||
| Diluted EPS Excluding Extraordinary Items | -0.381 | -0.344 | -0.459 | -0.346 | ||||||||||||||||||||||||||||||
| DPS - Common Stock Primary Issue | - | - | - | - | ||||||||||||||||||||||||||||||
| Diluted Normalized EPS | -0.283 | -0.215 | -0.287 | -0.286 | ||||||||||||||||||||||||||||||
* In Millions of (except for per share items)
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Write your thoughts about Provention Bio Inc
Are you sure you want to delete this chart?
Delete Cancel
Replace the attached chart with a new chart ?
Replace Cancel
Comment Guidelines
John Berry
Mar 13, 2023 4:31AM ET
Easy 300% winner
1
2
Mavi Yesil
Feb 13, 2023 12:24PM ET
I think they will produce insulin as pills
0
0
Mavi Yesil
Feb 13, 2023 12:05PM ET
The convenience foods we consume make us suffer from diabetes. Diabetes is also common in children under the age of 10. Sugar is the disease of humanity. Everyone around me uses insulin. Medicines for diabetes are humanity's greatest hope. This company will do great things. drug production is great. It gives hope and expectation.
0
0
John Avenetti
Aug 05, 2021 1:40PM ET
earnings? they're in clinical trials.
1
0
Tim Crum
May 27, 2021 5:54PM ET
going to pop tomorrow
0
0
John Avenetti
May 27, 2021 5:54PM ET
it seems likely
0
0
Tim Crum
May 27, 2021 5:54PM ET
why is premarket down? doesn't make sense. I see this as likely being approved as long as the PK data with FDA gets sorted out.
0
0
Szoka Krisztian
May 25, 2021 2:46PM ET
https://finance.yahoo.com/news/prvb-shareholder-alert-bronstein-gewirtz-140000371.html
0
0
Sean ONeal
Mar 11, 2021 6:55PM ET
interesting info https://www.jdrf.org/blog/2020/06/15/updates-teplizumab-trial-going-believe-results/
0
0
Tom Daniel
Mar 11, 2021 6:55PM ET
stock price doesn't GAF
0
0
SkyEmperor
Dec 10, 2020 10:13AM ET
Finally some movements
3
0
SkyEmperor
Nov 19, 2020 8:16AM ET
So i expected yesterday to have some impact the presentation,now what happened anyone knows? No big changes, still in range of 15
1
0
Gene Emory
Nov 19, 2020 8:16AM ET
Hold till news of fda approval. I see $100 by end of 2021. Happy trading...
1
0
Add Chart to Comment
Confirm Block
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
Report this comment
I feel that this comment is:
Comment flagged
Thank You!
Your report has been sent to our moderators for review